GLPwatch

Intentional overdose of liraglutide in a non-diabetic patient causing severe hypoglycemia.

CJEM · 2018

Last updated 2026-05-28

A non-diabetic person intentionally took too much liraglutide, a GLP-1 drug, and experienced severe low blood sugar. The patient needed hospital care, including a dextrose infusion and close monitoring in the intensive care unit. Prior reports did not link liraglutide overdose to hypoglycemia in diabetic patients.

AI summary of the abstract below.

JournalCJEM, 2018
Citations12
Relative citation ratio0.67
NIH percentile37
Molecules liraglutide

Abstract

ABSTRACTCases of liraglutide overdose are rare in the literature. Prior reports have not found hypoglycemia related to the medication overdose. We describe a case of a non-diabetic patient who intentionally overdosed on liraglutide leading to severe hypoglycemia. The patient required admission to the intensive care unit for a dextrose infusion and close monitoring. Glucagon-like protein-1 agonists are recognized for their safety and rarely causing hypoglycemia in diabetic patients. However, in this case the patient's non-diabetic status may have put him at risk for hypoglycemia in contrast to prior cases showing no hypoglycemia in diabetic patients. The case highlights the possible dangers of liraglutide overdose and need for blood glucose monitoring in the acute presentation.

Verbatim abstract via PubMed 29397808 ↗

Related research